已发表论文

改变前列腺癌患者中脂肪因子 omentin-1 的循环水平

 

Authors Zhou L, He W, Wang W, Zhou D

Received 8 December 2018

Accepted for publication 30 March 2019

Published 1 May 2019 Volume 2019:12 Pages 3313—3319

DOI https://doi.org/10.2147/OTT.S197507

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Amy Norman

Peer reviewer comments 3

Editor who approved publication: Dr Gaetano Romano

Background: Prostate cancer (PCa), one of the most common cancers in men, accounts for nearly 20% of adult malignant neoplasms. Omentin-1 is synthesized in visceral adipose tissue and its concentration in plasma changes with cancers. However, the association between omentin-1 and PCa was rarely studied. Thus, we investigated the plasma omentin-1 levels in PCa patients in Chinese population.
Materials and methods: Ninety cases of PCa and 90 matched healthy controls were enrolled in this study. We used ELISA technique to determine the concentration of omentin-1.
Results: The concentration of omentin-1 was higher in patients with PCa compared to controls (<0.001). Additionally, positive correlations were uncovered between omentin-1 with body mass index (r=0.240, =0.001), waist-hip ratio (r=0.228, =0.002), and prostate-specific antigen (r=0.589, <0.001). Receiver operating characteristic curve analysis indicated that plasma omentin-1 differentiated PCa patients from controls with a sensitivity of 85.9% and a specificity of 83.7%.
Conclusion: Our study demonstrated that the levels of plasma omentin-1 were increased in PCa patients. Meanwhile, omentin-1 may be a possible biomarker for diagnosing PCa. For validation, more studies should focus on and elucidate the potential mechanism underlying this change.
Keywords: omentin-1, prostate cancer, obesity, body mass index, adipokines




Figure 2 ROC curve analysis assessed the performance of omentin-1 levels in...